Oxidative phosphorylation

Oxidative phosphorylation
Name	Oxidative Phosphorylation
Caption	A simplified diagram of the electron transport chain within the mitochondrion.
Location	Mitochondrial inner membrane
Products	ATP, H<sub>2</sub>O
Precursors	NADH, FADH<sub>2</sub>, O<sub>2</sub>

Oxidative phosphorylation. This fundamental metabolic pathway is the final stage of cellular respiration, occurring within the mitochondrion of eukaryotic cells. It couples the oxidation of NADH and FADH₂ to the phosphorylation of ADP, producing the majority of ATP used by aerobic organisms. The process, central to bioenergetics, is driven by an electrochemical gradient established across the mitochondrial inner membrane.

Overview

Oxidative phosphorylation integrates two tightly coupled processes: the electron transport chain and chemiosmosis. The pathway begins with electron donors like NADH, generated from earlier stages such as the citric acid cycle and glycolysis. These electrons are transferred through a series of protein complexes embedded in the mitochondrial inner membrane, ultimately reducing molecular oxygen to form water. The energy released during this electron flow is used to pump protons across the membrane, creating a proton motive force that drives ATP synthase to produce ATP. This mechanism, known as the chemiosmotic theory, was elucidated by Peter D. Mitchell, earning him the Nobel Prize in Chemistry in 1978.

Electron transport chain

The electron transport chain consists of four major protein complexes and two mobile electron carriers. Complex I (NADH dehydrogenase) accepts electrons from NADH, transferring them to ubiquinone (CoQ) while pumping protons. Succinate dehydrogenase, also known as Complex II, feeds electrons from FADH₂ directly into the ubiquinone pool without proton translocation. Reduced ubiquinone then passes electrons to Complex III (cytochrome *bc*₁ complex), which transfers them to cytochrome c while pumping additional protons. Finally, Complex IV (cytochrome c oxidase), which contains copper centers and heme groups, catalyzes the reduction of oxygen to water with further proton pumping. The sequence of these complexes was historically determined through experiments using specific inhibitors like rotenone, antimycin A, and cyanide.

Chemiosmosis and ATP synthesis

The proton pumping activity of the electron transport chain establishes a substantial electrochemical gradient, or proton motive force, across the mitochondrial inner membrane. This force, comprising both a pH gradient and an electrical potential, provides the energy for ATP synthesis. ATP synthase (Complex V), a remarkable molecular motor studied by Paul D. Boyer and John E. Walker, utilizes this gradient. Protons flow back into the mitochondrial matrix through a channel in the F_O subunit of the enzyme, causing rotation of the F₁ subunit and driving the conformational changes that catalyze the phosphorylation of ADP to ATP. This rotary mechanism, for which John E. Walker and Paul D. Boyer shared the Nobel Prize in Chemistry in 1997, is a cornerstone of bioenergetics.

Regulation and control

The rate of oxidative phosphorylation is tightly regulated by cellular energy demands, primarily through the availability of ADP and inorganic phosphate, a principle known as respiratory control. Key regulators include the ATP/ADP ratio and the NADH/NAD+ ratio. Calcium ions, acting as a second messenger, can stimulate several dehydrogenase enzymes in the citric acid cycle, increasing electron donor supply. Thyroid hormones, such as thyroxine, can upregulate the synthesis of components like UCP1, influencing metabolic rate. Reactive oxygen species, inevitable byproducts of electron transport, can also modulate the activity of various components and signaling pathways, including those involving hypoxia-inducible factors.

Clinical significance

Defects in oxidative phosphorylation are linked to a range of serious human diseases, collectively termed mitochondrial diseases. These can arise from mutations in either mitochondrial DNA or nuclear DNA encoding components of the pathway. Notable disorders include Leber's hereditary optic neuropathy, often associated with mutations in Complex I genes, and MELAS syndrome, linked to tRNA mutations affecting mitochondrial protein synthesis. Furthermore, the process is a target for various toxins and poisons; cyanide and carbon monoxide inhibit Complex IV, while oligomycin blocks ATP synthase. Impaired oxidative phosphorylation is also implicated in the progression of neurodegenerative diseases like Parkinson's disease and in the metabolic alterations observed in many cancer cells, a phenomenon described by Otto Warburg.

Evolutionary origins

The evolutionary history of oxidative phosphorylation is deeply rooted in the endosymbiotic theory, which proposes that mitochondria originated from an alphaproteobacterial ancestor engulfed by an ancestral eukaryotic host. Key protein complexes, particularly ATP synthase, have homologs in modern bacteria and archaea, such as the F₁F_O ATPase found in *E. coli*. The electron transport chain components show evolutionary conservation from simple prokaryotic respiratory chains to the more complex systems in eukaryotes. This pathway was critical for enabling efficient aerobic metabolism, driving major evolutionary transitions and the diversification of complex multicellular life during events like the Great Oxidation Event.

Category:Metabolism Category:Cellular respiration Category:Mitochondria